Sex Differences in Susceptibility to Carcinogens

Seminars in Oncology

Volumn 36, Issue 6, 2009, Pages 516-523

  Ramchandran, Kavitha ^a   Patel, Jyoti D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CIGARETTE SMOKE; CYTOCHROME P450 ISOENZYME; ESTROGEN;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DNA REPAIR; ESTROGEN ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG FUNCTION; LUNG SMALL CELL CANCER; MALE; METABOLISM; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; UNITED STATES;

CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE SUSCEPTIBILITY; DNA ADDUCTS; DNA REPAIR; ESTROGENS; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; NICOTINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, ESTROGEN; RISK FACTORS; SEX FACTORS;

EID: 71049115590     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2009.09.005     Document Type: Article

References (82)

1. In: Horner M.J., Ries L.A.G., Krapcho M., Neyman N., Aminou R., Howlader N., et al. (Eds). SEER cancer statistics review, 1975-2006 (2009), National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2006/ http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission; posted to the SEER web site
2. Gan W.Q., Man S.F., Postma D.S., Camp P., and Sin D.D. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 7 (2006) 52-60
3. Ferguson M.K., Skosey C., Hoffman P.C., and Golomb H.M. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 8 (1990) 1402-1407
4. Radzikowska E., Glaz P., and Roszkowski K. Lung cancer in women: Age, smoking, histology, performance status, stage, initial treatment and survival-population-based study of 20,561 cases. Ann Oncol 13 (2002) 1087-1093
5. Thun M.J., Lally C.A., Flannery J.T., Calle E.E., Flanders W.D., and Heath Jr. C.W. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 89 (1997) 1580-1586
6. Ferguson M.K., Skosey C., Hoffman P.C., and Golomb H.M. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 8 (1990) 1402-1407
7. Ramaswamy G., Page N., Morgensztern D., Read W., Tierney R., Vlahiotis A., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results Database. J Clin Oncol 24 (2006) 4539-4544
8. Edmonson J.H., Lagakos S.W., and Selawry O.S. Cyclosphosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. Cancer Treat Rep 60 (1976) 925-932
9. Ramalingam S., Pawlish K., and Gadgeel S. Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results Database. Am J Clin Oncol 16 (1998) 651-657
10. Mitsudomi T., Tateishi M., Oka T., Yano T., Ishida T., and Sugimachi K. Longer survival after resection of non-small cell lung cancer in Japanese women. Ann Thorac Surg 48 (1989) 639-642
11. Radzikowska E., Glaz P., and Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival-population-based study of 20,561 cases. Ann Oncol 13 (2002) 1087-1093
12. Minami H., Yoshimura M., Miyamoto Y., Matsuoka H., and Tsubota N. Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer. Chest 118 (2000) 1603-1609
13. Moore K.A., Mery C.M., Jaklitsch M.T., Estocin A.P., Bueno R., Swanson S.J., et al. Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. Ann Thorac Surg 76 (2003) 1789-1795
14. Moore R., Doherty D., Chamberlain R., and Khuri F. Sex differences in survival in non-small cell lung cancer patients 1974-1998. Acta Oncol 43 (2004) 57-64
15. Risch H.A., Howe G.R., Jain M., Burch J.D., Holowaty E.J., and Miller A.B. Are female smokers at higher risk for lung cancer than male smokers?. A case-control analysis by histologic type. Am J Epidemiol 138 (1993) 281-293
16. Zang E.A., and Wynder E.L. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 88 (1996) 183-192
17. Henschke C.I., and Miettinen O. Women's susceptibility to tobacco carcinogens. Lung Cancer 43 (2004) 1-5
18. Bach P.B., Kattan M.W., Thornquist M.D., Kris M.G., Tate R.C., Barnett M.J., et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 95 (2003) 470-478
19. Bain C., Feskanich D., Speizer F.E., Thun M., Hertzmark E., Rosner B.A., et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 96 (2004) 826-834
20. Wakelee H.A., Chang E.T., Gomez S.L., Keegan T.H., Feskanich D., Clarke C.A., et al. Lung cancer incidence in never smokers. J Clin Oncol 25 (2007) 472-478
21. Dunnill M.S. The problem of lung growth. Thorax 37 (1982) 561-564
22. Merkus P.J.F.M., ten Have-Opbroek A.A.W., and Quanjer P.H. Human lung growth: a review. Pediatr Pulmonol 21 (1992) 383-397
23. Tager I.B., Segal M.R., Speizer F.E., and Weiss S.T. The natural history of forced expiratory volumes. The effect of cigarette smoking and respiratory symptoms. Am Rev Resp Dis 138 (1988) 837-849
24. Kanner R.E., Connett J.E., Altose M.D., Buist A.S., Lee W.W., Tashkin D.P., et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med 150 (1994) 956-961
25. Bakke P.S., Baste V., and Gulsvik A. Bronchial responsiveness in a Norwegian community. Am Rev Respir Dis 143 (1991) 317-322
26. Kanner R.E., Connett J.E., Altose M.D., Buist A.S., Lee W.W., Tashkin D.P., et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD: the Lung Health Study. Am J Respir Crit Care Med 150 (1994) 956-961
27. Gold D.R., Wang X., Wypig D., Spiezer F.E., Ware J.H., and Dockery D.W. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 335 (1996) 931-937
28. Prescott E., Bjerg A.M., Andersen P.K., Lange P., and Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 10 (1997) 822-827
29. Gan W.Q., Man S.F., Postma D.S., Camp P., and Sin D.D. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 29 (2006) 52-60 7
30. Centers for Disease Control and Prevention. Trends in cigarette smoking among high school students-United States, 1991-2001. Morb Mortal Wkly Rep 51 (2002) 409-412
31. Johnston L., Bachman J., and O'Malley P.M. Monitoring the future: questionnaire responses from the nation's high school seniors 1997 (2001), Institute for Social Research, University of Michigan, Ann Arbor, MI
32. Wiencke J.K., Thurston S.W., Kelsey K.T., Varkonyi A., Wain J.C., Mark E.J., et al. Early age of smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst 91 (1999) 614-619
33. Pierce L., Lee L., and Gilpin E.A. Smoking initiation by adolescent girls, 1944- 1988. An association with targeted advertising. JAMA 271 (1994) 608-611
34. Hegmann K.T., Fraser A.M., Keaney R.P., Moser S.E., Nilasena D.S., Sedlars M., et al. The age of smoking initiation on lung cancer risk. Epidemiology 4 (1993) 444-448
35. Busse W.W., and Lemanske R.F. Asthma. N Engl J Med 344 (2001) 350-362
36. Chen Y., Stewart P., Johansen H., McRae L., and Taylor G. Sex difference in hospitalization due to asthma in relation to age. J Clin Epidemiol 56 (2003) 180-187
37. Schatz M., Clark S., and Camargo C.A. Sex differences in the presentation and course of asthma hospitalizations. Chest 129 (2006) 50-55
38. Tantisira K.G., Colvin R., Tonascia J., Strunk R.C., Weiss S.T., and Fuhlbrigge A.L. Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. Am J Respir Crit Care Med 178 (2008) 325-331
39. Troisi R.J., Speizer F.E., Willett W.C., Trichopoulos D., and Rosner B. Menopause, postmenopausal estrogen preparations and the risk of adult-onset asthma: a prospective cohort study. Am J Respir Crit Care Med 152 (1995) 1183-1188
40. Barr R.D., Wentowski C.C., Grodstein F., Somers S.C., Stampfler J.M., Schwartz J., et al. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med 164 (2004) 379-386
41. Tan K.S., McFarlane L.C., and Lipworth B.J. Modulation of airway reactivity and peak flow variability in asthmatics receiving the oral contraceptive pill. Am J Respir Crit Care Med 155 (1997) 1273-1277
42. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: executive summary 2006. Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.goldcopd.org Accessed March 16, 2009
43. Stockely R.A. Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med 160 (1999) S49-S52
44. Mannino D., Homa D., Akinbami L., Ford E., and Redd S. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Surveill Summ 51 (2002) 1-16
45. Carrasco Garrido P., de Miguel Diez J., and Rejas Gutierrez J. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med 9 (2009) 2
46. Carter R., Nicotra B., and Huber G. Differing effects of airway obstruction on physical work capacity and ventilation in men and women with COPD. Chest 106 (1994) 1730-1739
47. Wasswa-Kintu S., Gan W.Q., Man S.F., Pare P.D., and Sin D.D. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 60 (2005) 570-575
48. Chapman K.R., Tashkin D.P., and Pye D.J. Gender bias in the diagnosis of COPD. Chest 119 (2001) 1691-1695
49. McLemore T.L., Adelber S., Liu M.C., McMahon N.A., Yu S.J., Hubbard W.C., et al. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarrette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 82 (1990) 1333-1339
50. Rossini A., de Almeida Simão T., Albano R.M., and Pinto L.F. CYP2A6 polymorphisms and risk for tobacco-related cancers. Pharmacogenomics 9 (2008) 1737-1752
51. Mollerup S., Ryberg D., Hewer A., Phillips D.H., and Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59 (1999) 3317-3320
52. Han W., Pentecost B.T., Pietropaolo R.L., Fasco M.J., and Spivack S.D. Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol Carcinog 44 (2005) 202-211
53. Hayes C.L., Spink D.C., Spink B.C., Cao J.Q., Walker N.J., and Sutter T.R. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci U S A 93 (1996) 9776-9781
54. Spink D.C., Katz B.H., Hussain M.M., Pentecost B.T., Cao Z., and Spink B.C. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 12 (2003) 1941-1950
55. Han W., Pentecost B.T., Pietropaolo R.L., Fasco M.J., and Spivack S.D. Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol Carcinog 44 (2005) 202-211
56. Chichester C.H., Buckpitt A.R., Chang A., and Plopper C.G. Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells. Mol Pharmacol 45 (1994) 664-672
57. Forkert P.G., Dowsley T.F., Lee R.P., Hong J.Y., and Ulreich J.B. Differential formation of 1,1-dichloroethylene-metabolites in the lungs of adult and weanling male and female mice: correlation with severities of bronchiolar cytotoxicity. J Pharmacol Exp Ther 279 (1996) 1484-1490
58. Seymour B.W., Friebertshauser K.E., Peake J.L., Pinkerton K.E., Coffman R.L., et al. Gender differences in the allergic response of mice neonatally exposed to environmental tobacco smoke. Dev Immunol 9 (2002) 47-54
59. Al Koudsi N., Mwenifumbo J.C., Sellers E.M., Benowitz N.L., Swan G.E., et al. Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics. Eur J Clin Pharmacol 62 (2006) 481-484
60. Mollerup S., Ryberg D., Hewer A., Phillips D.H., and Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59 (1999) 3317-3320
61. Daniel V. Glutathione S-transferases: gene structure and regulation of expression. Crit Rev Biochem Mol Biol 28 (1993) 173-207
62. Bell D., Taylor J., Paulson D., Robertson C.N., Mohler J.L., and Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85 (1993) 1159-1164
63. McWilliams J.E., Sanderson B.J., Harris E.L., Richert-Boe K.E., and Henner W.D. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4 (1995) 589-594
64. Tang D., Rundle A., Warburton D., Santella R.M., Tsai W.Y., Chiamprasert S., et al. Associations between both genetic and environmentals biomarkers and lung cancer: evidence of a greater risk of lung cancer in women in smokers. Carcinogenesis 19 (1998) 1949-1953
65. Zhang G., Liu X., Farkas A.M., Parwani A.V., Lathrop K.L., Lenzner D., et al. Estrogen receptor beta functions through non-genomic mechanisms in lung cancer cells. Mol Endocrinol 23 (2009) 146-156
66. Nose N., Sugio K., and Oyama T. Association between estrogen receptor-β expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung. J Clin Oncol 27 (2009) 411-417
67. Kawai H., Ishii A., Washiya K., Konno T., Kon H., Yamaya C., et al. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res 11 (2005) 5084-5089
68. Márquez-Garbán D.C., Chen H.W., Fishbein M.C., Goodglick L., and Pietras R.J. Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 72 (2007) 135-143
69. Schabath M.B., Wu X., Vassilopoulou-Sellin R., Vaporciyan A.A., and Spitz M.R. Hormone replacement therapy and lung cancer risk: a case control analysis. Clin Cancer Res 10 (2004) 113-123
70. Kreuzer M., Gerken M., Heinrich J., Kreienbrock L., and Wichmann H.E. Hormonal factors and risk of lung cancer among women. Int J Epidemiol 32 (2003) 263-271
71. Ganti A., Sahmoun A.E., and Panwalker A.W. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 24 (2006) 59-63
72. Adami H.O., Persson I., Hoover R., Schairer C., and Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 44 (1989) 833-839
73. Taioli E., and Wynder E.L. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 86 (1994) 869-870
74. Wei Q., Cheng L., Amos C.I., Wang L.E., Guo Z., Hong W.K., et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92 (2000) 1764-1772
75. Travis W.D., Travis L.B., and Devesa S.S. Lung cancer. Cancer 75 (1995) S191-S202
76. Ikeda T., Kurita Y., Inutsuka S., Tanaka K., Nakanishi Y., Shigematsu N., et al. The changing pattern of lung cancer by histological type-a review of 1151 cases from a university hospital in Japan, 1970-1989. Lung Cancer 7 (1991) 157-164
77. Janssen-Heijnen M.L., Nab H.W., van Reek J., van der Heijden L.H., Schipper R., and Coebergh J.W. Striking changes in smoking behaviour and lung cancer incidence by histological type in south-east Netherlands, 1960-1991. Eur J Cancer 31A (1995) 949-952
78. Wynder E.L., and Muscat J.E. Environmental health issues. Environ Health Perspect Suppl 103 (1995)
79. Djordjevic M.V., Hoffmann D., and Hoffmann I. Nicotine regulates smoking patterns. Prev Med 26 (1997) 435-440
80. Fischer S., Spiegelhalder B., and Preussmann R. Influence of smoking parameters on the delivery of tobacco-specific nitrosamines in cigarette smoke-a contribution to relative risk evaluation. Carcinogenesis 10 (1989) 1059-1066
81. Thun M.J., Lally C.A., Flannery J.T., Calle E.E., Dana Flanders W., and Health Jr. C.W. Cigarette smoking and changes in the his-topathology of lung cancer. J Natl Cancer Inst 89 (1997) 1580-1586
82. Le Marchand L., Sivaraman L., Pierce L., Seifried A., Lum A., Wilkens L.R., et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58 (1998) 4858-4863